{"id":"W2004018927","doi":"10.1016/j.lungcan.2011.12.003","title":"Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: A real-world cost-effectiveness analysis","year":2012,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Ministry of Health; Canadian Centre for Applied Research in Cancer Control","funders":"BC Cancer Agency","keywords":"Erlotinib; Medicine; Lung cancer; Internal medicine; Oncology; Cost-effectiveness analysis; Cohort; Survival analysis; Erlotinib Hydrochloride; Cost effectiveness; Univariate analysis; Population; Cancer; Multivariate analysis; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007810163,0.001883178,0.004380126,0.002489761,0.000299477,0.002454957,0.001436403,0.001745669,0.005793755],"category_scores_gemma":[0.01635068,0.0009517714,0.01229297,0.003031362,0.000722226,0.002905512,0.0009421563,0.002444712,0.0002612481],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004859705,"about_ca_system_score_gemma":0.001940642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01130035,"about_ca_topic_score_gemma":0.00843124,"domain_scores_codex":[0.9935312,0.00492757,0.0003420374,0.0003635079,0.0004080329,0.0004276558],"domain_scores_gemma":[0.9876744,0.01005734,0.001273187,0.0002869696,0.0002763726,0.0004316955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.3394878,0.00403303,0.06510842,0.01153559,0.09337603,0.001147151,0.00021396,0.3442,0.001827231,0.005795288,0.006529605,0.1267459],"study_design_scores_gemma":[0.094863,0.06618287,0.1791199,0.003026081,0.2222313,0.003833977,0.001464345,0.4016009,0.002759102,0.0101818,0.01388472,0.000851893],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9339724,0.03531763,0.00590611,0.001830924,0.0002906939,0.001180463,0.01546252,0.0001278873,0.005911435],"genre_scores_gemma":[0.9910508,0.00352934,0.00167914,0.0002673939,0.00006126473,0.0001870581,0.002794649,0.00002048342,0.0004097182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01130035,"threshold_uncertainty_score":0.04130459,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0286214190087518,"score_gpt":0.4102303832821982,"score_spread":0.3816089642734464,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}